interestingly in today's presentation (slide 14):
"Healthcare Capital and Mergers, LLC (HCM) of Chicago were engaged to prepare a Business Valuation report as part of due diligence (annexed) - HCM's independent valuation of Medivet: $15,700,000"
Looks like the Fair Market Value of Medivet and Medivet America is split $4.184m & $11.516m respectively.
------------------------------
Page 6 in the annex states forecast revenue etc for Medivet (incl America):
Profit and Loss Summary:
($000s)
..............................................2011.......2012.........2013
Revenue*................................4,944.....4,958......23,107
Total Operating Expenses*.......4,479......3,753.....18,070
EBITDA*.....................................465.....1,205.......5,037
*The above revenue and EBITDA projections are from the client prepared business plan
------------------------------
Decent 2013 revenue projections & EBITDA, IMO. Will be huge for the SP if they can come close to hitting that mark. All pie in the sky, but promising nonetheless.
Not surprisingly it seems like a fair bit of the volume sitting on the bid side has been pulled today whilst all this information is being absorbed - Bid 1.13m /Ask 5.03m. Wouldn't be surprised to see the SP pull back to 1.5c ish until closer the date (or until more info becomes available.)
Add to My Watchlist
What is My Watchlist?